Abstract：Objective To investigate the effect of auxiliary treatment of Alprostadil in the hepatitis B cirrhosis and its influence on serum inflammatory factors.Methods A total of 80 patients with hepatitis B cirrhosis admitted to our hospital from June 2016 to June 2017 were divided into group A (n=40)and group B (n=40)according to systic randomazition method.Group A was treated with Telbivudine on the basis of conventional treatment,group B was given Alprostadil for auxiliary treatment on the basis of group A.The clinical efficacy of the two groups of patients after 3 months of treatment,the hepatitis B virus DNA level and the inflammatory factors levels including interleukin-6(IL-6),interleukin-22(IL-22)and high-sensitivity C reactive protein(hs-CRP)before and after treatment were compared.ResultsThe total effective rate in group B(90.00%)was higher than that in group A(67.50%),with statistically significant difference (P<0.05).The levels of HBV DNA after treatment in both groups were lower than those before treatment,but there was no significant difference between the two groups (P＞0.05).The levels of hs-CRP,IL-6 and IL-22 in two groups after treatment were lower than those before treatment,and the above indexes in group B were lower than those in group A,with statistically significant difference(P<0.05).Conclusion Alprostadil has a good adjuvant therapy for patients with hepatitis B cirrhosis,which can effectively control the DNA level of hepatitis B virus and the levels of inflammatory cytokines such as hs-CRP,IL-6 and IL-22.
朱可伟;肖灿辉;白玉燕; 平岖. 前列地尔辅助治疗乙型肝炎肝硬化的效果及对血清炎性因子的影响[J]. 中国当代医药, 2018, 25(15): 102-104.
ZHU Ke-wei;XIAO Can-hui;BAI Yu-yan;PING Qu. Effect of auxiliary treatment of Alprostadil in the hepatitis B cirrhosis and its influence on serum inflammatory factors. 中国当代医药, 2018, 25(15): 102-104.
京公网安备 11010502046607号